Implementation of model-informed precision dosing for tamoxifen therapy in patients with breast cancer: A prospective intervention study

Authors: van Nijnatten, Ruben Y.M. ^a, Buijs, Sanne M. ^{a, ⁎, 1}, Agema, Bram C. ^{a, 1}, Fischer, Raphaël M.J. ^a, Moghaddam-Helmantel, Inge Ghobadi ^a, Contant, Caroline M.E. ^b, de Jongh, Felix E. ^c, Huijben, Auke M.T. ^d, Kop, Manon ^e, van der Padt-Pruijsten, Annemieke ^f, Zuetenhorst, Hanneke J.M. ^g, van Schaik, Ron H.N. ^h, Koch, Birgit C.P. ⁱ, Jager, A. ^a, Koolen, Stijn L.W. ^{a, i}, Mathijssen, Ron H.J. ^a

Source: In The Breast February 2025 79

Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group

Authors: Vincent, Jeroen, Wegdam, Johannes A., Haberkorn, Brigitte C.M., van der Harst, Erwin, Hendriks, Mathijs P., Schreurs, W.H. Hermien, Cense, Huib A., Rietbroek, Ron C., de Gier, Marie-José, van Breugel, Edwin A., de Vos, Aad I., Brosens, Rebecca P.M., Doornebosch, P.G., de Jongh, Felix E., Vles, Wouter J., den Boer, Marien O., Leijtens, Jeroen W.A., Gelderblom, A.J. Hans, Peeters, Koen C.M.J., Kuenen, Bart C., Pultrum, Bareld B., van Dodewaard-de Jong, Joyce M., Consten, Esther C.J., van de Wouw, A.J. Yes, Konsten, J.L.M., Hoekstra, R., Lutke Holzik, Martijn F., Vos, Allert H., van Hoogstraten, M.J., Schlesinger, Nis H., Creemers, Geert-Jan, de Hingh, Ignace H.J.T., Kjær, Monica L., Petersen, Lone N., Seiersen, Michael, Altaf, Rahim, van Cruijsen, Hester, Hess, Daniël A., van Leeuwen-Snoeks, Lobke L., Pronk, Apollo, Baeten, Coen I.M., van der Deure, Wendy M., Bosscha, Koop, Schut, Heidi, Leclercq, W.K.G., Simkens, L.H.J., Reijnders, Koen, van Arkel, Kees, van Grevenstein, W.M.U. Helma, van de Ven, Anthony W.H., Vuylsteke, Ronald J.C.L.M., Kuijer, Philomeen, Bakker, Sandra D., Goei, Hauwy, Helgason, Helgi H., van Acker, Gijs J.D., Temizkan, Mehmet, van Tilburg, Marc W.A., Gerhards, Michael F., Kerver, E.D., Gootjes, Elske, Nieboer, Peter, Bleeker, Wim A., Bleeker, G.R., van der Kruijssen, D.E.W., Elias, S.G., van de Ven, P.M., van Rooijen, K.L., Lam-Boer, J.’t, Mol, L., Punt, C.J.A., Sommeijer, D.W., Tanis, P.J., Nielsen, J.D., Yilmaz, M.K., van Riel, J.M.G.H., Wasowiz-Kemps, D.K., Loosveld, O.J.L., van der Schelling, G.P., de Groot, J.W.B., van Westreenen, H.L., Jakobsen, H.L., Fromm, A.L., Hamberg, P., Verseveld, M., Jaensch, C., Liposits, G.I., van Duijvendijk, P., Oulad Hadj, J., van der Hoeven, J.A.B., Trajkovic, M., de Wilt, J.H.W., Koopman, M.

Source: In Annals of Oncology September 2024 35(9):769-779

An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA

Authors: Vitale, Silvia R., Sieuwerts, Anieta M., Beije, Nick, Kraan, Jaco, Angus, Lindsay, Mostert, Bianca, Reijm, Esther A., Van, Ngoc M., van Marion, Ronald, Dirix, Luc Y., Hamberg, Paul, de Jongh, Felix E., Jager, Agnes, Foekens, John A., Vigneri, Paolo, Sleijfer, Stefan, Jansen, Maurice P.H.M., Martens, John W.M.

Source: In The Journal of Molecular Diagnostics January 2019 21(1):123-137

Cost and Clinical Benefits Associated with Oncotype DX® Test in Patients with Early-Stage HR+/HER2- Node-Negative Breast Cancer in the Netherlands.

Authors: de Jongh, Felix E.¹ (AUTHOR), Efe, Reva² (AUTHOR), Herrmann, Kirsten H.³ (AUTHOR), Spoorendonk, Jelle A.² (AUTHOR)

Source: International Journal of Breast Cancer. 9/22/2022, p1-12. 12p.

Subject Terms: *COST benefit analysis, *BREAST cancer, *ADJUVANT chemotherapy, *COMBINATION drug therapy, *TUMOR classification, *CANCER relapse, *GENETIC testing, *ONCOLOGISTS

Geographic Terms: NETHERLANDS

Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor

Authors: Beije, Nick, Onstenk, Wendy, Kraan, Jaco, Sieuwerts, Anieta M., Hamberg, Paul, Dirix, Luc Y., Brouwer, Anja, de Jongh, Felix E., Jager, Agnes, Seynaeve, Caroline M., Van, Ngoc M., Foekens, John A., Martens, John W.M., Sleijfer, Stefan

Source: In Neoplasia November 2016 18(11):647-653

Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer

Authors: Onstenk, Wendy ^*, Sieuwerts, Anieta M., Weekhout, Marleen, Mostert, Bianca, Reijm, Esther A., van Deurzen, Carolien H.M., Bolt-de Vries, Joan B., Peeters, Dieter J., Hamberg, Paul, Seynaeve, Caroline, Jager, Agnes, de Jongh, Felix E., Smid, Marcel, Dirix, Luc Y., Kehrer, Diederik F.S., van Galen, Anne, Ramirez-Moreno, Raquel, Kraan, Jaco, Van, Mai, Gratama, Jan W., Martens, John W.M., Foekens, John A., Sleijfer, Stefan

Source: In Cancer Letters 28 June 2015 362(1):36-44

Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group

Authors: Simkens, Lieke H J, van Tinteren, Harm, May, Anne, ten Tije, Albert J, Creemers, Geert-Jan M, Loosveld, Olaf J L, de Jongh, Felix E, Erdkamp, Frans L G, Erjavec, Zoran, van der Torren, Adelheid M E, Tol, Jolien, Braun, Hans J J, Nieboer, Peter, van der Hoeven, Jacobus J M, Haasjes, Janny G, Jansen, Rob L H, Wals, Jaap, Cats, Annemieke, Derleyn, Veerle A, Honkoop, Aafke H, Mol, Linda, Punt, Cornelis J A, Koopman, Miriam

Source: In The Lancet 9-15 May 2015 385(9980):1843-1852

A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands.

Authors: Simons, Martijn J. H. G., Machielsen, Peter M., Spoorendonk, Jelle A., Ignacio, Tim, Drost, Pieter B., Jacobs, Tim, de Jongh, Felix E.

Source: Journal of Medical Economics; Jan-Dec2024, Vol. 27 Issue 1, p445-454, 10p

Subject Terms: EPIDERMAL growth factor receptors, ADJUVANT chemotherapy, EPIDERMAL growth factor, GENE expression profiling, HORMONE receptors

Trastuzumab beyond progression: Overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer

Authors: von Minckwitz, Gunter, Schwedler, Kathrin, Schmidt, Marcus, Barinoff, Jana, Mundhenke, Christoph, Cufer, Tanja, Maartense, Eduard, de Jongh, Felix E., Baumann, Klaus H., Bischoff, Joachim, Harbeck, Nadia, Lück, Hans-Joachim, Maass, Nicolai, Zielinski, Christoph, Andersson, Michael, Stein, Robert C., Nekljudova, Valentina, Loibl, Sibylle

Source: In European Journal of Cancer October 2011 47(15):2273-2281

The addition of pravastatin to chemotherapy in advanced gastric carcinoma: A randomised phase II trial

Authors: Konings, Inge R.H.M., van der Gaast, A., van der Wijk, Lidemarie J., de Jongh, Felix E., Eskens, Ferry A.L.M., Sleijfer, Stefan

Source: In European Journal of Cancer 2010 46(18):3200-3204

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Population pharmacokinetics of cisplatin in adult cancer patients.

Authors: de Jongh, Felix E.^1,2 fe.de.jongh@ikazia.nl, Gallo, James M.³, Shen, Meiyu³, Verweij, Jaap¹, Sparreboom, Alex¹

Source: Cancer Chemotherapy & Pharmacology. Aug2004, Vol. 54 Issue 2, p105-112. 8p.

Subject Terms: *PHARMACOKINETICS, *CISPLATIN, *ANTINEOPLASTIC agents, *CREATINE, *ALKYLATING agents, *DRUG metabolism

The effects of smoking on anti-saccades: A study in regular smokers.

Authors: Roos, Yvo B.W.E.M., de Jongh, Felix E., Crevits, Luc

Source: Neuro-Ophthalmology; 1995, Vol. 15 Issue 1, p3-8, 6p

The effect of smoking on ocular saccadic latency time.

Authors: Roos, Yvo B.W.E.M., De Jongh, Felix E., Crevits, Luc

Source: Neuro-Ophthalmology; 1993, Vol. 13 Issue 2, p75-79, 5p